A new report based on national prescription data shows weight-loss drug use is rising among kids and teens. GLP-1 medications, like Ozempic and Wegovy, are drugs originally developed to treat ...

Findings also show improved persistence with high-potency, obesity-approved GLP-1 products In addition to persistence and adherence insights, the Year-3 study found 38% of individuals switched GLP ...

Overpaying for GLP-1 medications is extremely common, with a new data analysis of 102,166 drugs showing that 92% of those prescriptions could have been filled at a lower price. The DoseSpot analysis ...

Now used for type 2 diabetes, new study shows GLP-1 drugs helped people with type 1 keep blood glucose levels in a healthy range while also losing weight.

The use of behavioral health services decreased dramatically for patients prescribed GLP-1 drugs during the study period.

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 receptor agonists semaglutide or tirzepatide, at the end of two years ...

Eli Lilly announced successful results from its phase 3 trial of Orforglipron, the first-ever GLP-1, once-daily oral pill for weight loss and type 2 diabetes management.

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for diabetes and weight loss.

Head-to-head study shows bariatric surgery superior to GLP-1 drugs for weight loss Five times more weight loss with metabolic and bariatric surgery after two years Reports and Proceedings American ...